Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC
In conclusion, miR-124 may function as a tumor suppressive miRNA, and hypermethylation-mediated inactivation of miR-124 may be useful for a poor prognostic marker for ESCC patients.
Source: Clinical and Experimental Metastasis - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Genetics | Skin Cancer | Squamous Cell Carcinoma | Study